The study analyzed 283 discogenic lower back pain cases from eight articles from Pubmed and ScienceDirect up to Sept. 13, 2023. Researchers measured clinical outcomes with the visual analog scale and Oswestry Disability Index.
Functional outcomes in stem cell therapy patients showed significant improvement in both measures, and subgroup analysis for bone marrow aspirate concentrate showed similar improvements.
The study concluded, “Stem cell therapy could be beneficial as an option of treatment for discogenic LBP in improving pain and activity of daily living.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
